{"transactions":[{"id":2592283,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2021-08-24T19:03:21.000Z","date":"2021-08-20","kind":"tax_withholding","acquired":false,"shares":4307,"price":14.05,"value":60513.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction."}],"balance_after":277831,"source":{"system":"sec-edgar","filing":"0001179110-21-008402","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911021008402/edgar.xml","form_type":"4"}},{"id":2698670,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2021-05-24T18:18:01.000Z","date":"2021-05-20","kind":"tax_withholding","acquired":false,"shares":4310,"price":17.8,"value":76718.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,401 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 14, 2021."}],"balance_after":282138,"source":{"system":"sec-edgar","filing":"0001179110-21-005850","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911021005850/edgar.xml","form_type":"4"}},{"id":2838901,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2021-02-23T18:15:40.000Z","date":"2021-02-20","kind":"tax_withholding","acquired":false,"shares":31869,"price":18.79,"value":598818.51,"ownership":{"direct":true},"balance_after":285047,"source":{"system":"sec-edgar","filing":"0001179110-21-002174","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911021002174/edgar.xml","form_type":"4"}},{"id":2868921,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2021-02-10T17:51:46.000Z","date":"2021-02-08","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":316916,"source":{"system":"sec-edgar","filing":"0001179110-21-001540","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911021001540/edgar.xml","form_type":"4"}},{"id":2967820,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2020-11-24T18:22:46.000Z","date":"2020-11-20","kind":"tax_withholding","acquired":false,"shares":4807,"price":17.21,"value":82728.47,"ownership":{"direct":true},"balance_after":251916,"source":{"system":"sec-edgar","filing":"0001179110-20-011375","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911020011375/edgar.xml","form_type":"4"}},{"id":3048576,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2020-08-24T18:34:05.000Z","date":"2020-08-20","kind":"tax_withholding","acquired":false,"shares":4804,"price":18.22,"value":87528.88,"ownership":{"direct":true},"balance_after":256723,"source":{"system":"sec-edgar","filing":"0001179110-20-009273","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911020009273/edgar.xml","form_type":"4"}},{"id":3136964,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2020-05-22T18:11:54.000Z","date":"2020-05-20","kind":"tax_withholding","acquired":false,"shares":4807,"price":26.67,"value":128202.69,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,402 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2020."}],"balance_after":261527,"source":{"system":"sec-edgar","filing":"0001179110-20-006532","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911020006532/edgar.xml","form_type":"4"}},{"id":3252682,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2020-02-24T19:13:58.000Z","date":"2020-02-20","kind":"tax_withholding","acquired":false,"shares":29402,"price":25.9,"value":761511.8,"ownership":{"direct":true},"balance_after":264932,"source":{"system":"sec-edgar","filing":"0001179110-20-002154","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911020002154/edgar.xml","form_type":"4"}},{"id":3288449,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2020-02-05T19:05:10.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 3, 2020, the performance conditions applicable to 54,000 shares were achieved and such shares will vest on February 20, 2021, subject to the reporting person's continued service."}],"balance_after":294334,"source":{"system":"sec-edgar","filing":"0001179110-20-001208","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911020001208/edgar.xml","form_type":"4"}},{"id":3288448,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2020-02-05T19:05:10.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":240334,"source":{"system":"sec-edgar","filing":"0001179110-20-001208","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911020001208/edgar.xml","form_type":"4"}},{"id":3361017,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2019-11-22T18:25:38.000Z","date":"2019-11-20","kind":"tax_withholding","acquired":false,"shares":3567,"price":17.6,"value":62779.2,"ownership":{"direct":true},"balance_after":175334,"source":{"system":"sec-edgar","filing":"0001179110-19-012021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911019012021/edgar.xml","form_type":"4"}},{"id":3431029,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2019-08-22T18:06:26.000Z","date":"2019-08-20","kind":"tax_withholding","acquired":false,"shares":3084,"price":21.51,"value":66336.84,"ownership":{"direct":true},"balance_after":178901,"source":{"system":"sec-edgar","filing":"0001179110-19-009796","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911019009796/edgar.xml","form_type":"4"}},{"id":3515007,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2019-05-22T18:15:28.000Z","date":"2019-05-20","kind":"tax_withholding","acquired":false,"shares":2488,"price":19.84,"value":49361.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,027 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2019."}],"balance_after":181985,"source":{"system":"sec-edgar","filing":"0001179110-19-006534","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911019006534/edgar.xml","form_type":"4"}},{"id":3638515,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2019-02-22T18:22:12.000Z","date":"2019-02-20","kind":"tax_withholding","acquired":false,"shares":5798,"price":27,"value":156546.0,"ownership":{"direct":true},"balance_after":183446,"source":{"system":"sec-edgar","filing":"0001179110-19-002429","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911019002429/edgar.xml","form_type":"4"}},{"id":3670234,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2019-02-07T17:49:49.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":47250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On February 5, 2019, the performance conditions applicable to 47,250 shares were achieved and such shares will vest on February 20, 2020, subject to the reporting person's continued service."}],"balance_after":189244,"source":{"system":"sec-edgar","filing":"0001179110-19-001570","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911019001570/edgar.xml","form_type":"4"}},{"id":3670233,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2019-02-07T17:49:49.000Z","date":"2019-02-05","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":141994,"source":{"system":"sec-edgar","filing":"0001179110-19-001570","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911019001570/edgar.xml","form_type":"4"}},{"id":3754507,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-11-21T17:46:36.000Z","date":"2018-11-20","kind":"tax_withholding","acquired":false,"shares":7006,"price":24.79,"value":173678.74,"ownership":{"direct":true},"balance_after":76994,"source":{"system":"sec-edgar","filing":"0001179110-18-013110","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018013110/edgar.xml","form_type":"4"}},{"id":3830327,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-08-29T18:24:08.000Z","date":"2018-08-27","kind":"sale","acquired":false,"shares":7119,"price":27.712,"value":197281.728,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $27.65 to $27.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":84000,"source":{"system":"sec-edgar","filing":"0001179110-18-011003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018011003/edgar.xml","form_type":"4"}},{"id":3835809,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-08-22T19:34:42.000Z","date":"2018-08-20","kind":"tax_withholding","acquired":false,"shares":7005,"price":26.95,"value":188784.75,"ownership":{"direct":true},"balance_after":91119,"source":{"system":"sec-edgar","filing":"0001179110-18-010822","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018010822/edgar.xml","form_type":"4"}},{"id":3848399,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-08-09T19:46:33.000Z","date":"2018-08-08","kind":"sale","acquired":false,"shares":25355,"price":27.8518,"value":706182.389,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices from $27.63 to $28.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":98124,"source":{"system":"sec-edgar","filing":"0001179110-18-010467","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018010467/edgar.xml","form_type":"4"}},{"id":3848398,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-08-09T19:46:33.000Z","date":"2018-08-07","kind":"sale","acquired":false,"shares":4127,"price":28.0315,"value":115686.0005,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices from $28.015 to $28.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":123479,"source":{"system":"sec-edgar","filing":"0001179110-18-010467","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018010467/edgar.xml","form_type":"4"}},{"id":3848397,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-08-09T19:46:33.000Z","date":"2018-08-07","kind":"sale","acquired":false,"shares":1818,"price":28.9916,"value":52706.7288,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $28.60 to $29.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":127606,"source":{"system":"sec-edgar","filing":"0001179110-18-010467","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018010467/edgar.xml","form_type":"4"}},{"id":3899829,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-06-08T19:34:14.000Z","date":"2018-06-08","kind":"sale","acquired":false,"shares":3900,"price":23.6564,"value":92259.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices from $23.50 to $24.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":129424,"source":{"system":"sec-edgar","filing":"0001179110-18-008316","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018008316/edgar.xml","form_type":"4"}},{"id":3899828,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-06-08T19:34:14.000Z","date":"2018-06-06","kind":"sale","acquired":false,"shares":10140,"price":24.0895,"value":244267.53,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $24.05 to $24.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":133324,"source":{"system":"sec-edgar","filing":"0001179110-18-008316","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018008316/edgar.xml","form_type":"4"}},{"id":3921871,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-05-22T19:02:50.000Z","date":"2018-05-20","kind":"tax_withholding","acquired":false,"shares":21812,"price":24.31,"value":530249.72,"ownership":{"direct":true},"balance_after":143464,"source":{"system":"sec-edgar","filing":"0001179110-18-007375","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018007375/edgar.xml","form_type":"4"}},{"id":3930641,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-05-16T19:04:53.000Z","date":"2018-05-14","kind":"grant","acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 15, 2016, the reporting person was granted a performance stock award that vests based on the achievement of certain performance conditions over a five-year timeframe from 2016 through December 31, 2020 and continued employment. On May 14, 2018, the performance conditions applicable to 33,750 shares were achieved and such shares will vest on May 20, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 865 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2018."}],"balance_after":165276,"source":{"system":"sec-edgar","filing":"0001179110-18-006939","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018006939/edgar.xml","form_type":"4"}},{"id":4039984,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-02-22T17:41:06.000Z","date":"2018-02-20","kind":"tax_withholding","acquired":false,"shares":5587,"price":29.09,"value":162525.83,"ownership":{"direct":true},"balance_after":130661,"source":{"system":"sec-edgar","filing":"0001179110-18-002612","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018002612/edgar.xml","form_type":"4"}},{"id":4057882,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2018-02-14T18:22:22.000Z","date":"2018-02-12","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":136248,"source":{"system":"sec-edgar","filing":"0001179110-18-002127","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911018002127/edgar.xml","form_type":"4"}},{"id":4152445,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2017-11-22T16:40:17.000Z","date":"2017-11-20","kind":"tax_withholding","acquired":false,"shares":7079,"price":28.58,"value":202317.82,"ownership":{"direct":true},"balance_after":127248,"source":{"system":"sec-edgar","filing":"0001179110-17-014566","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911017014566/edgar.xml","form_type":"4"}},{"id":4213505,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2017-09-08T18:53:07.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":14670,"price":30.7669,"value":451350.423,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $30.69 to $30.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":134327,"source":{"system":"sec-edgar","filing":"0001179110-17-012159","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911017012159/edgar.xml","form_type":"4"}},{"id":4227457,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2017-08-22T18:30:35.000Z","date":"2017-08-20","kind":"tax_withholding","acquired":false,"shares":7079,"price":27.4,"value":193964.6,"ownership":{"direct":true},"balance_after":148997,"source":{"system":"sec-edgar","filing":"0001179110-17-011751","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911017011751/edgar.xml","form_type":"4"}},{"id":4307961,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2017-05-23T20:00:58.000Z","date":"2017-05-20","kind":"tax_withholding","acquired":false,"shares":7079,"price":36.83,"value":260719.57,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,702 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on May 15, 2017."}],"balance_after":156076,"source":{"system":"sec-edgar","filing":"0001179110-17-007881","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911017007881/edgar.xml","form_type":"4"}},{"id":4397158,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2017-03-07T19:05:22.000Z","date":"2017-03-03","kind":"sale","acquired":false,"shares":26829,"price":31.86,"value":854771.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices from $31.86 to $31.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares and prices at which the transactions set forth in footnotes (1) through (3) to this Form 4 were effected."}],"balance_after":161453,"source":{"system":"sec-edgar","filing":"0001179110-17-004176","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911017004176/edgar.xml","form_type":"4"}},{"id":4431146,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2017-02-22T19:07:46.000Z","date":"2017-02-20","kind":"tax_withholding","acquired":false,"shares":12440,"price":33.78,"value":420223.2,"ownership":{"direct":true},"balance_after":188282,"source":{"system":"sec-edgar","filing":"0001179110-17-002994","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911017002994/edgar.xml","form_type":"4"}},{"id":4461382,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2017-02-08T19:09:31.000Z","date":"2017-02-06","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200722,"source":{"system":"sec-edgar","filing":"0001179110-17-002002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911017002002/edgar.xml","form_type":"4"}},{"id":4544817,"issuer":{"id":5037,"kind":"organization","name":"Theravance Biopharma, Inc.","symbol":"TBPH"},"owners":[{"id":136083,"kind":"person","name":"Shafer Bradford J","position":1,"cik":"0001302448","reported_name":"Shafer Bradford J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Counsel, Secretary"}}],"security":"Ordinary Shares","published_at":"2016-11-22T18:04:50.000Z","date":"2016-11-20","kind":"tax_withholding","acquired":false,"shares":4008,"price":31.96,"value":128095.68,"ownership":{"direct":true},"balance_after":191722,"source":{"system":"sec-edgar","filing":"0001179110-16-031980","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1302448/000117911016031980/edgar.xml","form_type":"4"}}]}